# Bendeka

NDC: 63459-348
Generic name: bendamustine hydrochloride
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20151208

FDA application: NDA208194

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63459-348"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63459-348
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ace9a43b-f9bd-4896-abfe-0ef4fec67ddf